CHEBI:50751 - anti-estrogen

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name anti-estrogen ChEBI ID CHEBI:50751 Definition A drug which acts to reduce estrogenic activity in the body, either by reducing the amount of estrogen or by reducing the activity of whatever estrogen is present. Stars This entity has been manually annotated by the ChEBI Team. Wikipedia License Read full article at Wikipedia ChEBI Ontology Outgoing anti-estrogen (CHEBI:50751) is a drug (CHEBI:23888) Incoming 9,9-bis(4-hydroxyphenyl)fluorene (CHEBI:136855) has role anti-estrogen (CHEBI:50751) clomiphene citrate (CHEBI:3753) has role anti-estrogen (CHEBI:50751) danazol (CHEBI:4315) has role anti-estrogen (CHEBI:50751) elacestrant (CHEBI:229213) has role anti-estrogen (CHEBI:50751) furowanin B (CHEBI:65934) has role anti-estrogen (CHEBI:50751) glyceollin III (CHEBI:52086) has role anti-estrogen (CHEBI:50751) ICI-164384 (CHEBI:40710) has role anti-estrogen (CHEBI:50751) leuprolide (CHEBI:6427) has role anti-estrogen (CHEBI:50751) millewanin G (CHEBI:66391) has role anti-estrogen (CHEBI:50751) millewanin H (CHEBI:66392) has role anti-estrogen (CHEBI:50751) monoisopropyl phthalate (CHEBI:132587) has role anti-estrogen (CHEBI:50751) monopentyl phthalate (CHEBI:132578) has role anti-estrogen (CHEBI:50751) nafarelin (CHEBI:7445) has role anti-estrogen (CHEBI:50751) nafarelin acetate (CHEBI:167202) has role anti-estrogen (CHEBI:50751) nafarelin acetate hydrate (CHEBI:7446) has role anti-estrogen (CHEBI:50751) RU 58668 (CHEBI:90223) has role anti-estrogen (CHEBI:50751) tamoxifen N-oxide (CHEBI:63825) has role anti-estrogen (CHEBI:50751) Synonyms Sources anti-estrogenic agent ChEBI anti-estrogenic drug ChEBI anti-oestrogen ChEBI anti-oestrogenic agent ChEBI anti-oestrogenic drug ChEBI antiestrogen ChEBI antiestrogenic agent ChEBI antiestrogenic drug ChEBI antioestrogen ChEBI antioestrogenic agent ChEBI antioestrogenic drug ChEBI Manual Xref Database Antiestrogen Wikipedia View more database links Last Modified 15 January 2024